510(k) device
Trv
Interacoustics A/S · Apparatus, Vestibular Analysis (LXV, Unclassified) · First FDA decision May 27, 2020, newest May 27, 2020
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
5
Naming "Trv"
MAUDE reports
0
Brand "Trv", since 2015
PubMed studies
1,237
Mentioning "Trv"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Trv
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- TRV510(k)
K192652 · Decided May 27, 2020 · 246 days after receipt
Device type: Apparatus, Vestibular Analysis (LXV) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Trv", any status and sponsor, newest update first.
- Treatment of Posterior Benign Paroxysmal Positional Vertigo With Mechanical Rotational Chair.Pivotal-lookingCompleted
Aalborg University HospitalAcademic, hospital or other
NCT05834452 · 102 participants · Start Apr 12, 2023 · Primary completion Aug 9, 2025
Device: Mechanical rotational chair · For: Benign Paroxysmal Positional Vertigo; BPPV
Sites: Aalborg, Denmark
- Comparison of Two Mechanical Rotation Chairs With Diagnostics of Benign Paroxysmal Positional Vertigo.Enrolling by invitation
Aalborg University HospitalAcademic, hospital or other
NCT07772973 · 200 participants (planned) · Start Sep 1, 2026 · Primary completion Dec 1, 2026
Device: TRV® (Interacoustics©, Middelfart, Denmark), mechanical rotational chair; Rotundum® (balcare GmbH©, Küsnacht, Switzerland), mechanical rotational chair. · For: Benign Paroxysmal Positional Vertigo (BPPV)
Sites: Aalborg, Denmark
- The Accuracy of Manual BPPV Diagnostics When Using VNG Goggles.Pivotal-lookingCompleted
Aalborg University HospitalAcademic, hospital or other
NCT05846711 · 215 participants · Start Apr 12, 2023 · Primary completion Jan 11, 2024
Device: TRV chair; VNG goggles and 1 more · For: Benign Paroxysmal Positional Vertigo; BPPV; Vertigo and 4 more
Sites: Aalborg, Denmark
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Trv", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LXV
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Trv"[tiab]. The summary above synthesizes these.
- Virus-induced gene silencing in tomato.
Liu Y, Schiff M, Dinesh-Kumar SP · Plant J · 2002Research Support, U.S. Gov't, Non-P.H.S.
- Activity and specificity of TRV-mediated gene editing in plants.
Ali Z, Abul-Faraj A, Piatek M, et al. · Plant Signal Behav · 2015Evaluation Study, Research Support, Non-U.S. Gov't
- TRV: a physiological biomarker in sickle cell disease.
Kato GJ · Pediatr Blood Cancer · 2012Editorial, Comment
- Virus-Based microRNA Silencing in Plants.
Zhao J, Wang G, Jiang H, et al. · Methods Mol Biol · 2020Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- Optimization of Tobacco Rattle Virus (TRV)-Based Virus-Induced Gene Silencing (VIGS) in Tomato.
Singh AK, Ghosh D, Chakraborty S · Methods Mol Biol · 2022Research Support, Non-U.S. Gov't
- Trans-reservoiral ventriculography (TRV).
Suzuki S, Ottomo M, Suzuki M · Acta Neurochir (Wien) · 1979Case Reports
- California TRV-based VIGS vectors mediate gene silencing at elevated temperatures but with greater growth stunting.
Rahman J, Baldwin IT, Gase K · BMC Plant Biol · 2021
- [Benign paroxysmal positional vertigo treatment].
West N, Hansen S, Bloch SL, et al. · Ugeskr Laeger · 2017Review
- Outcomes of Treatment of Multicanal Benign Paroxysmal Positional Vertigo by Means of TRV Chair.
Baydan-Aran M, Binay-Bolat K, Hançer-Aslan G, et al. · Audiol Neurootol · 2023
- Virus-Induced Gene Silencing (VIGS) in Chinese Jujube.
Zhang Y, Niu N, Li S, et al. · Plants (Basel) · 2023
- Physiological response of CmWRKY15-1 to chrysanthemum white rust based on TRV-VIGS.
Chen Q, Kuang A, Wu H, et al. · Front Plant Sci · 2023
- TRV-GFP: a modified Tobacco rattle virus vector for efficient and visualizable analysis of gene function.
Tian J, Pei H, Zhang S, et al. · J Exp Bot · 2014Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code LXV.
- GyroStimUltrathera Technologies, Inc. · 510(k) 2022
- OrionInteracoustics A/S · 510(k) 2020
- ClearEdge Balance SystemQuadrant Biosciences · 510(k) 2019
- EQ BalanceUpright Science, Inc. · 510(k) 2019
- K-D BalanceKing-Devick Technologies, Inc. · 510(k) 2018
- Vestibular Analysis ApparatusCapacity Sports, LLC · 510(k) 2012
- Nydiag 200Interacoustics A/S · 510(k) 2010
- Vertigone Bppv GoggleVertigone, Inc. · 510(k) 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.